Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InforSense was a leading provider of enterprise-wide integrative analytics and workflow automation software for the life sciences and healthcare industries. Founded in 1999 as a spin-out from Imperial College London, the company developed the Knowledge Discovery Environment (KDE), a platform that enabled researchers to integrate and analyze diverse data types from across the drug discovery and development lifecycle. Their solutions were widely used by major pharmaceutical companies for lead optimization, clinical trial analysis, and biomarker discovery. The company's software allowed users to build complex analytical workflows without extensive programming, facilitating faster decision-making in R&D. In 2009, InforSense was acquired by IDBS, which integrated the KDE technology into its own informatics suite to enhance its data analysis capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InforSense.